Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical management of small intestinal neuroendocrine tumours.

The British journal of surgery·2026
Same author

Anatomic-Functional Frame for Middle Hepatic Vein Management in Right/Left Graft Living Donor Liver Transplantation: Venous Mapping in Healthy Human Livers.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same author

Three-Dimensional Computed Tomography-Magnetic Resonance Cholangiopancreatography Imaging Fusion for Computer-Assisted Surgery Planning in Full Graft Living Donor Liver Transplant: A Single Centre Experience.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2025
Same author

Trends in the Management and Outcomes of Neuroendocrine Liver Metastases: A 3-decade, Multicenter Observational Cohort Study.

Annals of surgery·2024
Same author

Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force.

Journal of neuroendocrinology·2024
Same author

Somatostatin Receptor Imaging with [<sup>18</sup>F]FET-βAG-TOCA PET/CT and [<sup>68</sup>Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2024

Related Experiment Video

Updated: Jul 20, 2026

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

Left hepatic trisectionectomy for hepatobiliary malignancies.

Hauke Lang1, Georgios C Sotiropoulos, Eirini I Brokalaki

  • 1Department of General Surgery, Visceral Surgery and Transplantation, University Hospital of Essen, Essen, Germany. hauke.lang@uni-essen.de

Journal of the American College of Surgeons
|August 26, 2006
PubMed
Summary

Left hepatic trisectionectomy, an extensive liver resection, shows acceptable survival rates for advanced liver tumors. However, it carries significant risks, necessitating careful patient selection for optimal oncologic outcomes.

More Related Videos

Laparoscopic Left Lateral Sectionectomy: Guided by the Ligamentum Teres Hepatis and the Umbilical Fissure Vein
03:33

Laparoscopic Left Lateral Sectionectomy: Guided by the Ligamentum Teres Hepatis and the Umbilical Fissure Vein

Published on: September 27, 2024

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
09:51

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Published on: December 4, 2023

Related Experiment Videos

Last Updated: Jul 20, 2026

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

Laparoscopic Left Lateral Sectionectomy: Guided by the Ligamentum Teres Hepatis and the Umbilical Fissure Vein
03:33

Laparoscopic Left Lateral Sectionectomy: Guided by the Ligamentum Teres Hepatis and the Umbilical Fissure Vein

Published on: September 27, 2024

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
09:51

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Published on: December 4, 2023

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Gastroenterology

Background:

  • Left hepatic trisectionectomy is the most extensive form of liver resection.
  • Limited data exist on the long-term outcomes of this complex procedure.

Purpose of the Study:

  • To evaluate the long-term outcomes of patients undergoing left hepatic trisectionectomy.
  • To identify factors influencing survival and morbidity after this major liver surgery.

Main Methods:

  • A retrospective analysis of 52 patients who underwent left trisectionectomy between June 1998 and July 2004.
  • Data collected included patient characteristics, operative details, pathology, perioperative outcomes, and survival rates.

Main Results:

  • Operative morbidity was 50% and mortality was 11.9%. Additional procedures increased morbidity.
  • One-, three-, and five-year survival rates were 65%, 52%, and 33%, respectively.
  • R0 resection significantly improved survival (78% at 5 years) compared to R1 resection (7% at 5 years).

Conclusions:

  • Left hepatic trisectionectomy offers acceptable survival for advanced hepatobiliary malignancies and liver metastases.
  • The procedure is associated with higher mortality and morbidity than less extensive resections.
  • Clear selection criteria and focus on oncologic benefits are crucial for this operation.